Neurocrine Biosciences
NBIX
#1366
Rank
NZ$26.85 B
Marketcap
NZ$269.39
Share price
0.84%
Change (1 day)
21.82%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company